These data highlight the usefulness of amyloidosis mouse models in exploring the human AD1 (DAM-like) phenotype; however, it demonstrates that the additional presence of tau in the CNS could induce a different microglial phenotype. This evidence concerns the gene MAPT and amyloidosis.